20 years after "Unequal Treatment," why has so little changed?

It was the first major report to point to longstanding systemic racism as a key reason for the nation's deeply entrenched health disparities. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        20 years ago, a landmark report spotlighted systemic racism in medicine. Why has so little changed? By Usha Lee McFarling Brian Smedley, a health equity researcher at the Urban Institute, was the lead editor of "Unequal Treatment." (André Chung for STAT) While the anniversary of the landmark report "Unequal Treatment" raises deeply unsettling questions about why so little progress has been made on health disparities in the past 20 years, the question now is whether the spotlight aimed on racism in medicine by the pandemic will finally spark lasting change, or whether this moment of opportunity, too, will pass. Read More Sponsor content by Amgen In-depth biopharma, business, and policy analysis at your fingertips Developing medicines that will help patients in need is at the heart of what Amgen does, says David Reese, executive vice president, Research and Development at Amgen. “That’s why we’re here, it’s why I come to work every day.” But what exactly does it take to get there? Hear from David, scientists, and researchers about what it takes to bring a molecule from discovery to development. More great reads from STAT this week Introducing the STATUS List, the definitive accounting of leaders in the life sciences By STAT As mask mandates fade, experts say use of masks likely will not By Helen Branswell The nation hasn’t made much progress on health equity. These leaders forged ahead anyway By Usha Lee McFarling Health insurance tech companies, struggling to turn profits, bet on software to turn business around By Mohana Ravindranath Opinion: The FDA needs to take another look at laser-based ‘vaginal rejuvenation’ By Kristin E. Rojas Scientists take key step toward unraveling the genetic roots of ALS in a pair of studies By Jonathan Wosen The WHO’s chief scientist on Covid-19 vaccines, patent battles, and speeding up access in Africa By Ed Silverman Opinion: A preacher’s new calling: Connecting neuroscience researchers as a way to advance social justice By Rev. Alvin C. Hathaway Sr. Saturday, February 26, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser